Who owns BIONDVAX PHARMACEUTICALS LTD?
- Ticker: SCNI
- CUSIP Number: 09073q303
Tip: Access positions for across all investors
Analyze quarterly positions in Biondvax Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biondvax Pharmaceuticals stock
Who bought or sold BIONDVAX PHARMACEUTICALS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 62k | $16k | 100% | Jun 2026 |
|
| Armistice Capital | 36k | $9.1k | 100% | Jun 2026 |
|
| Virtu Financial | 20k | $5.0k | 100% | Jun 2026 |
|
| XTX Topco | 17k | $4.2k | -30% | Jun 2026 |
|
| Rhumbline Advisers | 14k | $3.4k | 620% | Jun 2026 |
|
| Intl Fcstone | 13k | $4.6k | 100% | Jun 2026 |
|
| Hrt Financial | 12k | $3.0k | 100% | Jun 2026 |
|
| Captrust Financial Advisors | 12k | $3.0k | 100% | Jun 2026 |
|
| UBS Group | 4.0k | $1.0k | 330% | Jun 2026 |
|
| Royal Bank of Canada | 815.00 | $0 | 100% | Jun 2026 |
|
| Morgan Stanley | 58.00 | $33.002000 | 0% | Mar 2026 |
|